People · Operator
Named in public records as an officer, director or promoter · active 2015–2023 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Gelesis Inc | — | Biotechnology | Series B | $37.7M | $1.3B | 2015 |
| Orgenesis Inc. | — | Biotechnology | Series A | $35.2M | $14.4M | 2023 |
Elliot Maltz at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Elliot Maltz on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Rishi Gupta | 1 | 12 |
| Elon Boms | 1 | 10 |
| David Sidransky | 1 | 7 |
| Eric Elenko | 1 | 4 |
| Robert Forrester | 1 | 4 |
| Victor Miller | 1 | 4 |
| Guy Yachin | 1 | 4 |
| Vered Caplan | 1 | 2 |
| John LaMattina | 1 | 2 |
| Yaron Adler | 1 | 2 |
| Meghan Fitzgerald | 1 | 2 |
| Yishai Zohar | 1 | 2 |
| Hugues Bultot | 1 | 1 |
| Mendy Axelrad | 1 | 1 |
| Etti Hanochi | 1 | 1 |
| Yachin Yachin | 1 | 1 |
| Neil Reithinger | 1 | 1 |
| Ferber Ferber | 1 | 1 |
| Sav DiPasquale | 1 | 1 |
| Dov Weinerg | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.